Literature DB >> 25118483

Contrast-enhanced ultrasonography in diagnosis of benign and malignant breast lesions.

X Y Wang, L K Kang, C Y Lan.   

Abstract

PURPOSE: This study aims to investigate the value of real-time contrast-enhanced ultrasonography (US) in differentiating benign and malignant breast lumps.
MATERIALS AND METHODS: Patients with breast lesions were observed. The enhancement form, intensity, and time-intensity curve were classified, and the characteristics of all the lesions were analyzed.
RESULTS: Inhomogeneous partial enhancement and entire enhancement were exhibited in most of the malignant lesions. High enhancements were observed in malignant lesions, whereas lower enhancement and no enhancement were exhibited in the benign tumors. The peak value and regression time were significantly different between the two groups.
CONCLUSION: There's a significant difference regarding the results of real-time contrast-enhanced ultrasound between the benign tumor and malignant tumor which would help to improve the diagnostic accuracy of breast neoplasms.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25118483

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  3 in total

1.  Regional Contrast-Enhanced Ultrasonography (CEUS) Characteristics of Breast Cancer and Correlation with Microvessel Density (MVD).

Authors:  Xiaoling Leng; Guofu Huang; Fucheng Ma; Lanhui Yao
Journal:  Med Sci Monit       Date:  2017-07-14

2.  Optimisation of ultrasound liver perfusion through a digital reference object and analysis tool.

Authors:  Ángel Alberich-Bayarri; Jose Tomás-Cucarella; Alfredo Torregrosa-Lloret; Javier Sáiz Rodriguez; Luis Martí-Bonmatí
Journal:  Eur Radiol Exp       Date:  2019-04-03

3.  Clinical Value of Contrast-Enhanced Ultrasound in Breast Cancer Diagnosis.

Authors:  Yingying Yuan; Ming Xu; Yi Ren; Lili He; Jiejie Chen; Li Sun
Journal:  Comput Math Methods Med       Date:  2022-09-05       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.